Clinical Features and Outcomes of Repeated Endoscopic Therapy for Esophagogastric Variceal Hemorrhage in Cirrhotic Patients: Ten-Year Real-World Analysis

Figure 4

The cumulative rebleeding rates in various groups. (a) The cumulative rebleeding rates in the viral group and the nonviral group. (b) The cumulative rebleeding rates in subgroups of non-viral cirrhosis patients. (c) The cumulative rebleeding rates in the cryptogenic group and the alcohol group. (d) The cumulative rebleeding rates in the cryptogenic group and the autoimmune group. (e) The cumulative rebleeding rates in the alcohol group and the autoimmune group.

(a)

(b)

(c)

(d)

(e)